LATE-stage trials for a leading coronavirus vaccine have been suspended after a study participant suffered a “potentially unexplained illness”. AstraZeneca has put on hold phase three trials of a vaccine being developed in collaboration with the University of Oxford. The Australian Government last month signed an agreement with the UK-based company to secure the potential COVID-19 vaccine, if its trials prove successful. In a statement, AstraZeneca said it “voluntarily paused” the phase 3 clinical trial — which kicked off in July — to allow a review of the “single event”…
Read MoreTag: oxford
New study reveals Oxford coronavirus vaccine produces strong immune response
A team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus. HealthTimes Reporter The results of the Phase I/II trial published today in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system. The vaccine provoked a T cell response within 14 days of vaccination (white blood cells that can attack cells infected with the SARS-CoV-2 virus), and an antibody…
Read More